These 8 stocks look like winners now as economic growth slows.
Read MoreWe could be in for a wild ride if the Fed surprises the market next week. Here’s what to expect no matter what the FOMC decides to do.
Read MoreOne technical analyst says its time to ditch the FAANGs in favor of these 5 stocks.
Read MoreTechnical indicators signal a violent sell-off could be right around the corner. Here’s what you need to know now.
Read MoreBuy Target $2.78 Sell Target $3.24 Trailing Stop 20% AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company also develops ZALVISO, a […]
Read MoreFor growth investors, stocks making new all-time highs are usually seen as the best kinds of stocks to buy. When new all-time highs happen at the top of a long-term upward trend, many of those same investors get even more excited, because traditional trend analysis usually suggests that those are among the highest-probability signals to […]
Read More